Peripheral Neuropathy Treatment Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029

Peripheral Neuropathy Treatment Market is estimated to grow at a CAGR of 4.3% during the forecast period. The increasing prevalence of diabetes and cancer and rising launches of generic versions of peripheral neuropathy drugs are some pivotal factors accelerating market growth. As per the International Diabetes Federation (IDF), in 2019, nearly 463 million adults (20-79 years) were suffering from diabetes, which is expected to reach 700 million by 2045. The most common diabetic complication is peripheral neuropathy. It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This condition affects the legs and feet first and is followed by hands and arms. 

Several prescription medications are available for diabetes-associated nerve pain. Some antidepressants provide ease to nerve pain. Tricyclic antidepressants may support mild to moderate nerve pain. This class of drugs includes imipramine (Tofranil), amitriptyline, and desipramine (Norpramin). With the increasing prevalence of diabetic neuropathy, some new launches of generic peripheral neuropathy drugs have been reported over the years. For instance, in July 2019, Rising Pharmaceuticals, Inc. declared the US launch of a generic version of Lyrica (pregabalin) capsules. These are available in eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg). 

Pregabalin capsules are designated for the treatment of neuropathic pain related to diabetic peripheral neuropathy, for the neuropathic pain management associated with spinal cord injury, for the management of fibromyalgia, for postherpetic neuralgia management, and for adjunctive therapy to treat partial-onset seizures in patients 4 years of age and older. The launch of generic drugs is offering a cost-effective treatment alternative for patients suffering from debilitating neuropathic pain conditions. This, in turn, will provide growth opportunities for the market.

To Request a Sample of our Report on Peripheral Neuropathy Treatment Market:  https://www.omrglobal.com/request-sample/peripheral-neuropathy-treatment-market

Peripheral Neuropathy Treatment Market-Segmentation

By Type

·        Antidepressants

·        Pain Relievers

·        Antiseizure 

·        Others 

By Application

·        Diabetes 

·        Chemotherapy-Induced 

·        Others

A full Report of Peripheral Neuropathy Treatment Market is Available @  https://www.omrglobal.com/industry-reports/peripheral-neuropathy-treatment-market

Regional Analysis

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

Company Profiles

·        Achelios Therapeutics, Inc.

·        Acorda Therapeutics, Inc.

·        Alembic Pharmaceuticals, Ltd. 

·        Amneal Pharmaceuticals LLC

·        Apotex, Inc.

·        Assertio Therapeutics, Inc.

·        Bristol Myers Squibb Co.

·        Cipla, Ltd. 

·        Daiichi Sankyo Company, Ltd. 

·        Eli Lilly and Co.

·        GlaxoSmithKline plc

·        Glenmark Pharmaceuticals, Ltd. 

·        Grünenthal GmbH 

·        Innovus Pharmaceuticals, Inc.

·        Johnson & Johnson Services, Inc.

·        Lupin, Ltd.

·        Mylan N.V.

·        Novartis International AG

·        Pfizer, Inc.

·        Teva Pharmaceutical Industries, Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peripheral-neuropathy-treatment-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more